06.19.2023 - By Mark Ebell and Michael Wilkes
Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER) '